Hidrokel

01Pathophysiology

The tunica vaginalis is a serous membrane derived from the processus vaginalis, an embryologic outpouching of the peritoneum that descends with the testis during fetal development. Normally, the processus vaginalis obliterates after testicular descent, leaving behind a closed potential space (the tunica vaginalis) that surrounds the anterolateral surface of the testis. A hydrocele forms when fluid accumulates within this space.

In communicating hydroceles, the processus vaginalis fails to obliterate completely, creating a persistent channel between the peritoneal cavity and the tunica vaginalis. Peritoneal fluid flows freely through this patent tract, which is why the swelling characteristically fluctuates in size throughout the day: it enlarges when the child is upright or straining (increased intra-abdominal pressure pushes fluid downward) and decreases when the child is supine (fluid drains back into the peritoneum). This is the predominant type in neonates and infants. It is worth noting that a communicating hydrocele shares the same anatomic defect as an indirect inguinal hernia (patent processus vaginalis), but the channel in a hydrocele is too narrow to allow bowel or omentum to pass through.

In non-communicating hydroceles, the processus vaginalis is fully obliterated, and the fluid collection is entirely contained within the closed tunica vaginalis. The fluid results from an imbalance between secretion and reabsorption by the mesothelial lining. This type does not change in size with position or Valsalva. In adults, non-communicating hydroceles may arise secondarily from epididymitis, orchitis, testicular torsion, trauma, or even a testicular tumor that disrupts lymphatic drainage. This is exactly why the exam will expect you to rule out underlying testicular pathology (particularly malignancy) in any adult presenting with a new hydrocele.

The reason the mass transilluminates is straightforward: the fluid within the tunica vaginalis is serous (clear, straw-colored), allowing light to pass through it. Solid masses such as tumors, herniated bowel, or hematoceles will not transilluminate.

02Classification and Clinical Manifestation

Clinical Manifestation

03Diagnostic Workup

The best initial test for evaluating a suspected hydrocele is transillumination. This is performed by placing a light source (penlight or otoscope without a speculum) against the posterior aspect of the scrotum in a darkened room. A hydrocele will glow with a characteristic reddish hue because the fluid is translucent. A solid mass (tumor, hernia containing bowel) will not transmit light and will appear opaque. Transillumination is quick, noninvasive, and essentially diagnostic at the bedside, but it cannot provide detail about underlying testicular anatomy.

The most accurate (confirmatory) test is scrotal ultrasound with Doppler. Ultrasound serves two purposes. First, it confirms the hydrocele by demonstrating an anechoic fluid collection surrounding the testis within the tunica vaginalis. Second, and critically in adult patients, it evaluates the underlying testicular parenchyma to rule out an occult testicular mass. Remember: any adult presenting with a new-onset hydrocele warrants ultrasound to exclude testicular cancer, because a tumor can cause a reactive (secondary) hydrocele by obstructing lymphatic drainage. Doppler interrogation also confirms normal testicular blood flow, helping to exclude torsion.

In adults where clinical suspicion for malignancy exists (firm testis on palpation, history of cryptorchidism, age 15 to 35), serum tumor markers including alpha-fetoprotein, beta-hCG, and lactate dehydrogenase should be obtained alongside ultrasound.

In neonates and infants, imaging is generally unnecessary when the clinical presentation is classic (painless, transilluminant, reducible with position). Ultrasound is reserved for atypical features such as pain, firmness, or failure to resolve.

04Management and Treatment

In neonates and infants, the initial management for both communicating and non-communicating hydroceles is observation. The rationale is that the processus vaginalis continues to undergo physiologic obliteration during the first year of life, and the majority of hydroceles will resolve without intervention by 12 to 18 months of age. Parents should be counseled on warning signs that warrant earlier evaluation, including sudden increase in size (which may indicate hernia development), pain, redness, or firmness.

Surgical intervention is indicated when: (1) a communicating hydrocele persists beyond 12 to 18 months, (2) there is a coexisting inguinal hernia, or (3) the hydrocele is large enough to cause discomfort. In children, the surgical approach is through an inguinal incision, and the procedure involves high ligation of the processus vaginalis at the internal inguinal ring. This is essentially the same operative principle as pediatric indirect inguinal hernia repair.

In adults, symptomatic hydroceles that cause discomfort, cosmetic concern, or are large enough to interfere with daily activities are treated with hydrocelectomy. Two common surgical techniques include:

• Jaboulay eversion (bottle procedure): the tunica vaginalis is opened, the fluid is drained, and the sac is everted and sutured behind the spermatic cord so it cannot re-accumulate fluid. This is preferred for large, thick-walled hydroceles.

• Lord plication: the tunica vaginalis is plicated (gathered with sutures) without excision. This is less traumatic and preferred for thin-walled hydroceles, as it reduces the risk of hematoma formation.

Aspiration of the hydrocele (with or without sclerotherapy) is generally discouraged because the recurrence rate is extremely high. It carries additional risks of infection and hematocele formation. Aspiration is reserved only for patients who are poor surgical candidates due to comorbidities.

For secondary hydroceles, the critical principle is to treat the underlying pathology first. If the hydrocele is reactive to epididymitis, antibiotics directed at the causative organism are the priority. If there is a suspicion for testicular malignancy, the next step is radical inguinal orchiectomy (never trans-scrotal biopsy, which risks seeding the scrotum), and the hydrocele is addressed as part of that management.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The single most common trap on this topic involves transillumination as the distinguishing feature. Students frequently confuse hydrocele with inguinal hernia because both can present as scrotal swelling that changes in size. The vignette will contain the phrase "the mass transilluminates" or describe a scrotal swelling that glows when a light is placed behind it. This is your anchor for hydrocele. If the swelling does not transilluminate, you are dealing with something else (hernia, tumor, hematocele).

The second major trap is the adult with a new hydrocele. Many students will select "observation" or "reassurance" as the answer, applying the pediatric management principle. This is wrong. In an adult, a new hydrocele demands scrotal ultrasound to exclude an underlying testicular tumor. The exam is testing whether you recognize that a secondary hydrocele can be the presenting sign of testicular cancer.

A third tested concept is the management timeline in children. Students sometimes recommend surgery too early. The expected answer for neonatal communicating hydrocele is observation for 12 to 18 months. Surgery is only indicated if the hydrocele persists beyond that window or if there is evidence of a concurrent inguinal hernia.

Finally, remember that aspiration is never the answer for definitive management. The exam will offer aspiration as a tempting option, especially in elderly patients. While aspiration may provide temporary relief, the correct definitive treatment remains surgical hydrocelectomy.

The core competency being tested across all these questions is pattern recognition: connecting a painless, transilluminant scrotal swelling to hydrocele, then correctly sequencing the workup (transillumination first, ultrasound to confirm and rule out malignancy) and choosing the appropriate management based on the patient's age and clinical context.